scholarly journals Statin Use Correlates with Reduced Risk of Pyogenic Liver Abscess: A Population-Based Case-Control Study

2017 ◽  
Vol 121 (2) ◽  
pp. 144-149 ◽  
Author(s):  
Kuan-Fu Liao ◽  
Kao-Chi Cheng ◽  
Cheng-Li Lin ◽  
Shih-Wei Lai
PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0178571 ◽  
Author(s):  
Sai-Wai Ho ◽  
Chao-Bin Yeh ◽  
Shun-Fa Yang ◽  
Han-Wei Yeh ◽  
Jing-Yang Huang ◽  
...  

2018 ◽  
Vol 53 (5) ◽  
pp. 785-792
Author(s):  
Y.-T. Yeh ◽  
B.-Y. Wang ◽  
C.-W. Lin ◽  
S.-F. Yang ◽  
S.-W. Ho ◽  
...  

2015 ◽  
Vol 95 (2) ◽  
pp. 227-232 ◽  
Author(s):  
C.Y. Huang ◽  
S.D. Chung ◽  
L.T. Kao ◽  
H.C. Lin ◽  
L.H. Wang

Introduction: Statin may induce epithelial dysfunction of the bladder urothelium. Epithelial dysfunction was proposed as one of the major potential etiologies for bladder pain syndrome/interstitial cystitis (BPS/IC). In this study, we examined the association between statin use and BPS/IC using a population-based study. Subjects and Methods: This case-control study used the Taiwan Longitudinal Health Insurance Database. In total, 815 female subjects with BPS/IC and 4075 randomly selected female controls were included. We used a conditional logistic regression to compute the odds ratio (OR) for having previously used statins between cases and controls. Results: A conditional logistic regression analysis showed that the OR of prior statin users for cases was 1.52 (95% confidence interval (CI): 1.19-1.94) compared to controls after adjusting for diabetes, hypertension, coronary heart disease, obesity, chronic pelvic pain, irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, panic disorder, migraines, sicca syndrome, allergies, endometriosis, and asthma. Furthermore, adjusted ORs of regular and irregular statin use for cases were 1.58 (95% CI: 1.20-2.08) and 1.53 (95% CI: 1.02-2.31), respectively, compared to controls. Conclusion: We concluded that there was an association between statin use and BPS/IC.


2015 ◽  
Vol 80 (4) ◽  
pp. 755-761 ◽  
Author(s):  
Yen-Chun Peng ◽  
Cheng-Li Lin ◽  
Wan-Yun Hsu ◽  
Chi-Sen Chang ◽  
Hong-Zen Yeh ◽  
...  

2013 ◽  
Vol 12 (3) ◽  
pp. 293-298 ◽  
Author(s):  
Te-Fu Chan ◽  
Hui-Fen Chiu ◽  
Chen-Hsuan Wu ◽  
Chih-Lung Lin ◽  
Chun-Yuh Yang

2021 ◽  
Author(s):  
Josephina G. Kuiper ◽  
Aline C. Fenneman ◽  
Anne H. van der Spek ◽  
Elena Rampanelli ◽  
Max Nieuwdorp ◽  
...  

Objective: Whether an association between oral levothyroxine use, leading to supraphysiological exposure of the colon to thyroid hormones, and risk of colorectal cancer exists in humans is unclear. We therefore aimed to assess whether the use of levothyroxine is associated with a reduced risk of colorectal cancer in a linked cohort of pharmacy and cancer data. Design: Population-based matched case-control study. Methods: A total of 28,121 patients diagnosed with colorectal cancer between 1998-2014 were matched to 106,086 controls. Multivariable logistic regression was used to estimate the association between levothyroxine use and occurrence of colorectal cancer, adjusted for potential confounders. Results were stratified by gender, age, tumour subtype and staging as well as treatment duration and dosing. Results: A total of 1066 colorectal cancer patients (4%) and 4024 (4%) controls had used levothyroxine at any point before index date (adjusted odds ratio 0.95 [0.88-1.01]). Long-term use of levothyroxine was seen in 323 (30%) colorectal cancer patients and 1111 (28%) controls (adjusted odds ratio 1.00 [0.88-1.13]). Stratification by tumour subsite showed a borderline significant risk reduction of rectal cancer, while this was not seen for proximal colon cancer or distal colon cancer. There was no relationship with treatment duration or with levothyroxine dose. Conclusions: In this study, no reduced risk of colorectal cancer was seen in levothyroxine users. When stratifying by tumour subsite, a borderline significant risk reduction of rectal cancer was found and may warrant further research.


Lung Cancer ◽  
2012 ◽  
Vol 75 (3) ◽  
pp. 275-279 ◽  
Author(s):  
Meng-Hsuan Cheng ◽  
Hui-Fen Chiu ◽  
Shu-Chen Ho ◽  
Chun-Yuh Yang

2011 ◽  
Vol 106 (5) ◽  
pp. 894-898 ◽  
Author(s):  
Hui-Fen Chiu ◽  
Shu-Chen Ho ◽  
Chih-Cheng Chen ◽  
Chun-Yuh Yang

Head & Neck ◽  
2019 ◽  
Vol 41 (5) ◽  
pp. 1193-1198 ◽  
Author(s):  
Li‐Ting Kao ◽  
Shih‐Han Hung ◽  
Pai‐Feng Kao ◽  
Ju‐Chi Liu ◽  
Herng‐Ching Lin

Sign in / Sign up

Export Citation Format

Share Document